ISPOR Europe 2026
Panel Real-World Evidence (RWE) track
Should Real-World Evidence Play a Role in Reimbursement Decisions on Decommissioning Health Technologies?
Mon, Nov 9, 2026 · 1:45–2:45 PM CET Hall K2, Level -2, Austria Center Vienna
About this session
Issue: As healthcare systems face growing pressure to allocate scarce resources to innovative health technologies, real-world evidence (RWE) is increasingly considered to support access decisions. However, the use of RWE to inform reassessment and potential decommissioning of existing health technologies is less established.
Speakers
-
Panelist
-
Novartis Pharma AG
Panelist
-
Karolinska Insitutet
Panelist